Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Weppler · SciRah

Researcher profile · Semantic Scholar

A. Weppler

Share profile

A. Weppler — researcher profile on SciRah

h-index: 17
Works: 44
Citations: 872

Most-cited papers

Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study.
I. Pires da Silva, T. Ahmed, I. Reijers, A. Weppler +24 more
2021The Lancet Oncology185 citations Open access
Semantic Scholar
Hematological immune related adverse events after treatment with immune checkpoint inhibitors.
Rafaela Kramer, A. Zaremba, Alvaro Moreira, S. Ugurel +29 more
2021European Journal of Cancer98 citations
Semantic Scholar
Longitudinal Monitoring of ctDNA in Patients with Melanoma and Brain Metastases Treated with Immune Checkpoint Inhibitors
Jenny H. J. Lee, A. Menzies, M. Carlino, A. McEvoy +13 more
2020Clinical Cancer Research72 citations
Semantic Scholar
FDG PET/CT for tumoral and systemic immune response monitoring of advanced melanoma during first-line combination ipilimumab and nivolumab treatment
A. Iravani, M. Osman, A. Weppler, R. Wallace +10 more
2020European Journal of Nuclear Medicine and Molecular Imaging57 citations
Semantic Scholar
Combination anti-PD1 and ipilimumab therapy in patients with advanced melanoma and pre-existing autoimmune disorders
L. Brown, A. Weppler, P. Bhave, C. Allayous +9 more
2021Journal for ImmunoTherapy of Cancer56 citations Open access
Semantic Scholar
A closer look at immune-mediated myocarditis in the era of combined checkpoint blockade and targeted therapies.
Christina Guo, M. Alexander, Youseph Dib, Peter K. H. Lau +8 more
2019European Journal of Cancer50 citations Open access
Semantic Scholar
γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient Survival
N. Gherardin, Kelly Waldeck, A. Caneborg, L. Martelotto +28 more
2021Cancer immunology research42 citations Open access
Semantic Scholar
Ipilimumab (IPI) alone or in combination with anti-PD-1 (IPI+PD1) in patients (pts) with metastatic melanoma (MM) resistant to PD1 monotherapy.
I. Pires da Silva, T. Ahmed, S. Lo, I. Reijers +16 more
202029 citations
Semantic Scholar
The role of local therapy in the treatment of solitary melanoma progression on immune checkpoint inhibition: A multicentre retrospective analysis.
J. Versluis, A. Hendriks, A. Weppler, L. Brown +27 more
2021European Journal of Cancer28 citations Open access
Semantic Scholar
Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES)
Peter K. H. Lau, B. Feran, Lorey K. Smith, A. Lasocki +19 more
2021Journal for ImmunoTherapy of Cancer27 citations Open access
Semantic Scholar
FDG PET/CT Prognostic Markers in Patients with Advanced Melanoma Treated with Ipilimumab and Nivolumab.
A. Iravani, R. Wallace, S. Lo, A. Galligan +3 more
2023Radiology26 citations
Semantic Scholar
Characterization of the treatment-naive immune microenvironment in melanoma with BRAF mutation
Min-Yu Wang, S. Zadeh, A. Pizzolla, K. Thia +12 more
2022Journal for ImmunoTherapy of Cancer25 citations Open access
Semantic Scholar
Emergency medicine ultrasonography in rural communities.
Candi J Flynn, A. Weppler, D. Theodoro, Elizabeth Haney +1 more
2012Canadian Journal of Rural Medicine24 citations
Semantic Scholar
Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment
A. Pizzolla, S. Keam, Ismael A. Vergara, F. Caramia +13 more
2022Journal for ImmunoTherapy of Cancer22 citations Open access
Semantic Scholar
Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis
A. Zaremba, Rafaela Kramer, V. DeTemple, S. Bertram +35 more
2021Frontiers in Oncology22 citations Open access
Semantic Scholar
Novel endoscopic scoring system for immune mediated colitis: A Multicenter Retrospective Study of 674 Patients
Ying-Hong Wang, Hamzah Abu-Sbeih, Tenglong Tang, Malek Shatila +27 more
2024Gastrointestinal Endoscopy21 citations Open access
Semantic Scholar
Durability of response to immune checkpoint inhibitors in metastatic Merkel cell carcinoma after treatment cessation.
A. Weppler, L. Da Meda, I. Pires da Silva, Wen Xu +12 more
2023European Journal of Cancer21 citations
Semantic Scholar
Refusal of colorectal cancer surgery in the United States: Predictors and associated cancer-specific mortality in a Surveillance, Epidemiology, and End Results (SEER) cohort
M. Delisle, Shubhi Singh, J. Howard, N. Panda +2 more
2020Surgery Open Science16 citations Open access
Semantic Scholar
Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma
A. Weppler, A. Pattison, P. Bhave, P. D. De Ieso +11 more
2020Journal for ImmunoTherapy of Cancer12 citations Open access
Semantic Scholar
Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis
A. Galligan, A. Iravani, A. Lasocki, R. Wallace +12 more
2023Frontiers in Endocrinology10 citations Open access
Semantic Scholar
SUN-127 Diagnostic Challenges Associated with the Rising Incidence of Endocrine Toxicity in the Era of Combination Immunotherapy
A. Galligan, A. Iravani, A. Lasocki, R. Wallace +9 more
2020Journal of the Endocrine Society5 citations Open access
Semantic Scholar
CHARLI: A phase Ib/II trial of ipilimumab-nivolumab-denosumab or nivolumab-denosumab in patients with unresectable stage III and IV melanoma.
Peter K. H. Lau, S. Harris, M. Eastgate, D. Kee +16 more
2023Journal of Clinical Oncology4 citations Open access
Semantic Scholar
Outcomes of immune checkpoint inhibitor-mediated colitis: Multicenter cohort study.
Hamzah Abu-Sbeih, Tenglong Tang, D. Faleck, M. Dougan +11 more
2021Journal of Clinical Oncology4 citations Open access
Semantic Scholar
Combination anti-PD-1 and ipilimumab (ipi) therapy in patients with advanced melanoma and pre-existing autoimmune disorders (AD).
L. Brown, A. Weppler, P. Bhave, C. Allayous +9 more
20204 citations
Semantic Scholar
Management of resected stage III/IV melanoma with adjuvant immunotherapy.
Rebecca Johnson, V. Atkinson, P. Bhave, A. Weppler +9 more
20213 citations
Semantic Scholar
Response assessment and immune-related adverse events as detected by FDG PET/CT in patients treated with combined CTLA-4 and PD-1 checkpoint inhibitors as first-line therapy in advanced melanoma
A. Iravani, M. Osman, M. Hofman, A. Weppler +3 more
20193 citations
Semantic Scholar
Durability of response to immune checkpoint inhibitors (ICI) in metastatic Merkel cell carcinoma (mMCC) after treatment cessation.
A. Weppler, L. Da Meda, I. Silva, Wen Xu +11 more
2021Journal of Clinical Oncology2 citations
Semantic Scholar
1080MO The value of local therapy in treatment of solitary melanoma progression upon immune checkpoint inhibition
J. Versluis, A. Hendriks, A. Weppler, L. Brown +16 more
20202 citations Open access
Semantic Scholar
MON-258 Hyperprolactinemia: An Unusual Initial Presenting Manifestation of Multiple Sclerosis
A. Galligan, A. Iravani, A. Lasocki, R. Wallace +9 more
2020Journal of the Endocrine Society2 citations Open access
Semantic Scholar
1079MO Progression of BRAF mutant CNS metastases are associated with a transcriptional network bearing similarities with the innate PD-1 resistant signature (IPRES)
Peter K. H. Lau, B. Feran, L. Smith, A. Lasocki +16 more
20201 citations Open access
Semantic Scholar
S720 Endoscopic Severity Score of Immune-Mediated Colitis Is More Effective in Guiding Medical Treatment Than Clinical Severity Grade
Hamzah Abu-Sbeih, Tenglong Tang, Malek Shatila, D. Faleck +26 more
2022American Journal of Gastroenterology0 citations
Semantic Scholar
ECHOCARDIOGRAPHIC FEATURES OF IMMUNE CHECKPOINT INHIBITOR ASSOCIATED MYOCARDITIS AND THEIR ASSOCIATION WITH ADVERSE OUTCOMES
Olusola A Orimoloye, J. Power, Joseph F. Nowatzke, Andrew Hughes +13 more
20210 citations Open access
Semantic Scholar
Checkpoint Inhibitors in the Treatment of Metastatic Melanoma
A. Weppler, Peter K. H. Lau, G. McArthur
2020Cutaneous Melanoma0 citations
Semantic Scholar
548 CD8+ tissue-resident memory T cells are tumour reactive and increase after immunotherapy in a case of metastatic mucosal melanoma
A. Pizzolla, S. Keam, Ismael A. Vergara, F. Caramia +15 more
2020Journal for ImmunoTherapy of Cancer0 citations Open access
Semantic Scholar
FDG-PET metabolic tumor volume in advanced melanoma treated with ipilimumab and nivolumab (ipi/nivo).
A. Iravani, R. Wallace, S. Lo, A. Galligan +9 more
20200 citations
Semantic Scholar
in of Combination Immunotherapy
A. Lasocki, R. Wallace, A. Weppler
20200 citations
Semantic Scholar
Abstract 15365: Natural History of Immune Checkpoint Inhibitor Associated Myocarditis With Preserved Ejection Fraction
Joseph F. Nowatzke, J. Power, Wouter C. Meijers, Olusola A Orimoloye +19 more
2020Circulation0 citations
Semantic Scholar
in of Combination Immunotherapy
A. Lasocki, R. Wallace, A. Weppler, N. Sachithanandan +2 more
20200 citations
Semantic Scholar
Checkpoint Inhibitors in the Treatment of Metastatic Melanoma
A. Weppler, Peter K. H. Lau, G. McArthur
2019Cutaneous Melanoma0 citations
Semantic Scholar
Clinical and FDG-PET markers of immune checkpoint inhibitor (ICI) response in patients with metastatic Merkel cell carcinoma (mMCC)
A. Weppler, P. Bhave, P. D. De Ieso, M. Chua +12 more
2019Annals of Oncology0 citations Open access
Semantic Scholar
Clinical and FDG-PET markers of immune checkpoint inhibitor (ICI) response in patients with metastatic Merkel cell carcinoma (mMCC).
A. Weppler, P. Bhave, P. D. De Ieso, J. Raleigh +11 more
2019Journal of Clinical Oncology0 citations
Semantic Scholar
PATTERNS AND PREVALENCE OF IMMUNE-RELATED ADVERSE EVENTS AS DETECTED WITH FDG PET/CT IN PATIENTS TREATED WITH COMBINED CTLA-4 AND PD-1 INHIBITOR AS FIRST-LINE THERAPY FOR ADVANCED MELANOMA
A. Iravani, M. Osman, Hofman, A. Weppler +3 more
20190 citations
Semantic Scholar
Gastrointestinal complications of melanoma immunotherapy in a large Australian cohort
A. Buckle, R. Vaughan, A. Weppler, S. Sandhu +1 more
20180 citations
Semantic Scholar
Evaluation of the risk of relapse of patients with stage III cutaneous melanoma at event-free survival time points.
A. Weppler, Derrick G. Lee, D. van Niekerk, K. Savage
20170 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Sandhu×27
Invite
S. Sandhu — researcher profile on SciRah
G. Au-Yeung×14
Invite
G. Au-Yeung — researcher profile on SciRah
G. Long×12
Invite
G. Long — researcher profile on SciRah
G. McArthur×12
Invite
G. McArthur — researcher profile on SciRah

×10

Invite

M. Carlino — researcher profile on SciRah

Invite

A. Menzies — researcher profile on SciRah

Invite

P. Bhave — researcher profile on SciRah

Invite

C. Lebbé — researcher profile on SciRah

Douglas B. Johnson×9

Invite

Douglas B. Johnson — researcher profile on SciRah

Invite

A. Iravani — researcher profile on SciRah

Invite

R. Wallace — researcher profile on SciRah

Invite

A. Lasocki — researcher profile on SciRah